Search Results 91-100 of 8944 for Ergot Alkaloids

  1. Gastroenterology and Hepatology - Clinical trials

    Mayo Clinic's Division of Gastroenterology and Hepatology offers treatment and specialty care for people with a wide range of rare and common digestive ...

  2. Dizziness. Too much potassium in the blood. Swelling of the skin due to extra fluid. Some people taking the angiotensin 2 receptor blocker olmesartan have ...

  3. Faculty - Department of Biochemistry and Molecular Biology - Mayo Clinic Research

    Faculty. To learn more about the research interests of individual faculty members in the Department of Biochemistry and Molecular Biology, including their ...

  4. Selected Publications by Faculty and Fellows Source: Cho, J. Seville, MT. Khanna, S. Pardi, DS. Sampathkumar, P. Kashyap, PC. Sc

    Source: Cho, J. Seville, MT. Khanna, S. Pardi, DS. Sampathkumar, P. Kashyap, PC. Screening for. Clostridium difficile colonization on admission to a ...

  5. International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) - Mayo Clinic

    About this study. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...

  6. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

    If stomach acid washes back into the esophagus, it can cause discomfort and may lead to precancerous changes in the lining of the esophagus.

  7. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

    If stomach acid washes back into the esophagus, it can cause discomfort and may lead to precancerous changes in the lining of the esophagus.

  8. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to evaluate molecular markers which might be a predictor of pancreatic cancer or precancer by analyzing the secretions (fluid) ...

  9. Cardiovascular Medicine - Clinical trials

    Learn more about clinical trials related to conditions of the heart and blood vessels.

  10. A Study To Evaluate Acalabrutinib With Or Without Obinutuzumab To Treat Early-Stage Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...